Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Bone cancer is characterized by uncontrolled growth of cells of the bone. Primary bone cancer (that arises directly in the bone), is relatively rare. Different types of bone tissue give rise to ...

Survival for patients with metastatic or relapsed osteosarcoma ... Inhibitors of the tumor microenvironment include bisphosphonates and VEGF inhibitors. The use of effective preclinical models ...

How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and ...